DatasetName,LARP4_S(381) LARP4_S(512) LARP4_S(583) LARP4_S(589) LARP4_S(597) LARP4_S(599) LARP4_S(642) LARP4_S(714) LARP4_S(717) LARP4_S(722) LARP4_T(595) LARP4_T(649) LARP4_Y(68) LARP4_Y(714),LARP4_S(132) LARP4_S(311) LARP4_S(391) LARP4_S(5) LARP4_S(505) LARP4_S(526) LARP4_S(572) LARP4_S(576) LARP4_S(592) LARP4_S(600) LARP4_S(603) LARP4_S(643) LARP4_S(647) LARP4_S(651) LARP4_S(660) LARP4_S(673) LARP4_S(728) LARP4_S(8) LARP4_T(579) LARP4_T(585) LARP4_T(588)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5910807481479511,
SR2019_MCF7_Biol_repl_3,0.5741391487042999,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,0.5986709820461336,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.6010138305065197,0.44642244643893103
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5882697299492466,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6180823542864616,0.45080398454150694
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5956348819631324,
SR2019_MDAMB231_Biol_repl_4,0.5992684115300216,
GF2025_P2_Sph,0.5781076950321333,0.44588248945862186
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6014066858909486,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.45134458352764767
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5956759389954129,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.608122386480824,0.46376243042912385
WZ2023_Pu_010_30min,0.6257752557539471,0.4550734822431006
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6198570956053201,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6329453948040614,0.4460008139213606
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.6114304692875149,
AH2018_SILAC_MR_2_N,0.5992674026376574,0.45250157871046265
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.6197689523482423,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5725403457381562,
UK2020_HCM_2,0.596585624276364,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.6071802774429849,0.44318633727071266
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5770009007362641,0.44906746174180967
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.6183932541238971,0.45037225203669007
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6248501520246791,0.4518897334479619
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.451528373286642
KBE2022_Log2_Ex_34_U,0.6013600324101286,
WZ2023_Pu_005_10min,0.6274261270365109,0.45558780541508676
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6030601811703828,0.44759677462063346
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.6087114517965156,
WZ2023_Pu_025_30min,0.6258756955129681,0.45443956726006907
AH2018_SILAC_MR_2_X,0.6057191107386964,0.45232833093648306
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.44869377948869
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5840745965715713,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5816062342384238,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.602000666537762,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6016719956280461,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.6016090063799407,
AH2018_LFQ_1_C,0.6107531137857629,0.4425072534864781
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6085681060107734,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6259040077129028,0.45394514529523133
CK2022_11 40-1,0.602210725155997,0.4474425361286099
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.60169868080194,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.6372052323086165,0.4485079281430218
FSO2013_Ratio H/L normalized Rep2,0.5935362101871894,
WZ2023_Pu_005_20min,0.6259550750224422,0.45605911829373624
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5915478493997716,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.6087794473749268,0.44536138990735336
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.593880674523949,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.44599021036496744
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6104102357168263,0.4496677205856487
CK2022_1 200-1,0.6032627948356516,0.4548359419934743
PG2020_Intensity Mock_10h_D,0.6115099468753512,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.598111024574983,0.4517930042832208
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5812998743890267,
PG2020_Intensity 2h_C,0.6120978025364271,0.44782538463566807
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6159658309078885,0.4490202366698598
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.44442189674131527
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6177786601140692,0.4488211703045081
CK2022_3 40-1,0.6110051415110147,0.4499046667863465
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.599896792559215,
HH2022_Reporter intensity 8,0.5875653281822154,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.6382764264333362,0.45242102625315234
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6017741217433336,
YA2020_Reporter_intensity_Normal_No.1,0.5929320909501508,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6016349150025869,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5768992182080466,0.44951068047978315
HS2024_8_I_T3,,
CF2017_EOC 3,0.5991091161672769,0.450213921693869
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.6051120703681495,
WZ2023_Pu_010_20min,0.6242444976079026,0.45419812544926574
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6109463291476532,0.44976134715033306
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.6013737374280101,0.4473736979636328
KS2014_Intensity N3,0.6027123860557265,0.4523123279937238
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5884450444155255,
FSO2013_Ratio H/M normalized Rep2,0.591631148485165,
RAM2015_Log2 A,0.6155639212216361,0.4548745419494842
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.6115953161870232,0.448952150307377
KS2014_Intensity E15_2,0.6378591197311158,0.44785281823512446
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.6140501998857548,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.602200530863075,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6097715848679124,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5987743851971865,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.45219324880708006
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6073996197873416,0.463229359928259
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6095097329514166,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.44902472259474974
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.6006707076209278,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5888141401497317,
FSO2013_Ratio M/L normalized Rep2,0.5966624418411418,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6046231062988079,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.6066722783044237,0.4494822556301917
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5985065301088154,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6037079304032612,
DL2023_control-1,,
AR2021_ALG 10 μM,0.6074664581156525,0.4621645823741036
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6010296352649386,
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.45002454790888724
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.6026621819613157,0.45786071717583665
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.6124827552198566,0.45030162148768466
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5882400457066382,
JW2021_After_3,,
GF2025_P8_Sph,0.5827374604514339,0.44770869834814775
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.601109542281993,
CK2022_11 200-1,0.5947334663856844,0.45310663164013015
CK2022_12 200-1,0.5956940207046394,0.4529420264969385
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.600565453689153,
WZ2023_Su_010_20min,0.6246369649529677,0.45282209807951285
AH2018_TMTMS2_2_N,0.6353470977590504,0.448747848701732
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5980716089674986,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.44882106247976145
AH2018_TMTMS3_Pool,0.6371520721213526,
KS2014_Intensity N4,0.6113357891992486,0.45817357134846304
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.6017880080930672,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.6107357163643993,0.4471860345655771
CK2022_14 200-1,0.5992217813413481,0.45548877950449373
SR2019_Hs578T_Biol_repl_1,0.5956741374267397,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.6352522112601233,0.4520055519265573
AST2020_anti-CD3+PDL2.2,,0.45136064364353407
PG2020_Intensity Mock_10h_A,0.617814043667263,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,0.5995794373559244,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.6024446724953402,0.4501429092793037
GF2025_P1_Adh,0.5911945782063969,0.4470957075842567
GF2025_P1_Sph,0.5897853340914384,0.45185324363753243
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6302015263273234,0.4550442846421664
CF2017_EOC 1,0.6014939377636269,0.4454924173426633
CK2022_3 200-1,0.6041284097501798,0.4542887155725406
AH2018_LFQ_IT_3_C,0.602925776544739,
SR2019_Hs578T_Biol_repl_2,0.591621566902441,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5695970883390219,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.5970423451760771,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.611628252357648,0.4500776607131583
RB2022_1_PostSprint,,
CK2022_4 200-1,0.6031919750786597,0.45427865288538816
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6029351441957326,0.44698156086998175
AR2021_ALG 1 μM,0.6011194169900802,0.4793779591426896
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.5759229888059229,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5851770096657981,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5976777792249689,0.4499816272148287
CK2022_9 16-1,0.5991807439792127,0.4471288544682881
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5988790596294187,0.4556083500302212
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.613116608903368,
CK2022_16 16-1,0.6008343094350462,0.45166539358248464
FS2019_db/db3,0.6039026709629495,
CK2022_15 40-1,0.6062847962111076,0.4498342673899605
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6264170292770774,0.4546441308603483
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5970039570720607,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6016004752828863,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6369382861603637,0.4518120112185078
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.6195310896031361,
KBE2022_Log2_Ex_27_U,0.610023424532001,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5893614677356463,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5975650675229779,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.6184949955513321,0.4254900590746581
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5977645652909825,0.44756227943413535
RN2012_L13,,0.45619374703730076
LG2023_Control-1_intensity,0.6030405094478112,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5935515273355803,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.60232272071224,0.44739578000808583
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5917343029021377,
HH2022_Reporter intensity 6,0.5894213182269535,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5813014108814588,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.572275807771863,
AH2018_TMTMS2_3_X,0.6346975393864209,0.44774170465993135
GF2025_P3_Adh,0.5893546850768052,0.449931524468393
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6342171091764465,0.4470116405954209
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.6039205408106636,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.6118925340572584,
YA2020_Reporter_intensity_Cancer_No.1,0.5998952793000821,
AST2020_Control,,0.4510031810293134
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.596348468252387,
LG2023_Control-2_intensity,0.6083492337698103,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5923475249412616,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6171833908693768,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6025856122822519,0.45167968459203567
HH2022_Reporter intensity 1,0.6191659895318364,0.45167501105828184
HH2022_Reporter intensity 2,0.6184777219224975,0.45200393602915656
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5979805020569376,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5826932399558028,0.46839201915136675
SR2019_LM2_Biol_repl_3,0.5974637929009542,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.590335082011735,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.585075607122236,
AR2021_KD 72h,0.6105006528908216,0.45686553520944967
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6066277923678983,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6392311575536109,0.45002864721196056
KBE2022_Log2_Ex_9_U,0.6112749270976169,
AH2018_SILAC_M_3_N,0.6020377032517382,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.6134666954639513,
CF2017_OSE 29,0.6141886683388537,0.4485570490922661
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5972854939579264,
RN2012_L12,,0.4452423296518454
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6024130316664352,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5941458750396054,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5709030795753123,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6053881488461327,0.4482729137711725
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,0.44668636128137024
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5894884584551352,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5977721058754136,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.6394915761508922,0.44688701698755134
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5980926371135776,0.45332916644173704
CK2022_5 200-1,0.5989946599646668,0.4534930952056057
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5937481314339602,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6134452867390959,0.4472108283415942
AH2018_SILAC_MR_1_X,0.6051580492804097,0.45186133558212355
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5965650389206738,
AH2018_SILAC_3_C,0.6024424781728107,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.592763667880203,
CK2022_4 16-1,0.6095792081030166,0.45040415199097367
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6174311800850315,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.6017984405776343,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.6146430457561486,
FSO2013_Ratio H/L normalized Rep3,0.5847837375794341,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.609103972738331,
AH2018_SILAC_IT_2_N,0.6073396767891815,
AH2018_SILAC_IT_1_X,0.6022771967636172,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.5953962102715492,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5853175161238531,0.4451021913609824
WZ2023_Pe_025_20min,0.6265894672220264,0.4545722557289712
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.6131651018899505,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.6331433942235369,0.44757552803443784
RN2012_H06,,0.45326152948288095
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6270941758158981,0.45633432216406145
SR2019_HCC1419_Biol_repl_4,0.5866185540614509,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.5851684290055497,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5936059921873105,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5993810729088063,
WZ2023_Su_025_10min,0.6258874035369467,0.4542906556550693
AH2018_LFQ_IT_4_X,0.60200071590373,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6263432892652494,0.4545707881856595
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.6122222831749623,
EP2017_Pervanadate R#1 log2 ratio,0.6092378874813517,0.4452280375861632
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,0.44987419353958125
KS2014_Intensity,0.6431867638021521,0.45532647130379816
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5958289642308088,
LY2019_P7+,0.6123313539419358,
EP2017_Untreated R#1 normalized log2 ratio,0.5772680360408754,0.45446336653422637
RN2012_L10,,0.4472261813901959
PG2020_Intensity 4h_C,0.6035944038564897,
EP2017_Mitotic R#3 normalized log2 ratio,0.5964226280064864,0.4470947231645465
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5958224133771111,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.6011460656925623,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.607791981361631,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5987599905804227,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.6005073352972428,0.4555390243485078
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.6079977584662697,0.4509119790724834
GF2025_P9_Sph,0.5786011347719001,0.4445393587560646
CK2022_6 200-1,0.5985196843367712,0.4532224620898105
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6381940875546276,0.4495486088685344
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.6011586875295757,
PG2020_Intensity 2h_D,0.6165611093619718,
EP2017_Untreated R#3 normalized log2 ratio,0.6108754354659096,0.44794562700041207
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5992191155796623,0.45332823416145435
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5759815319901789,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.6069880609559719,0.4387882136860136
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6030036010478048,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6101206854426058,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.44289461340967534
AH2018_SILAC_MR_3_N,0.6067141741825057,0.4525655438867003
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.6093535924782423,0.4446513774071975
PG2020_Intensity CT_C,0.6178462179319784,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.6052885173109451,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6097997554041974,
EP2017_Untreated R#3 log2 ratio,0.6099754088046548,0.4472839689638339
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5868853357644611,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.6019489124320992,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6071408972864255,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5848674057776083,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.581174453916141,0.44594058011460413
YA2020_Reporter_intensity_Normal_No.2,0.5937722502297713,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.61422106434972,0.4495900370846737
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6177009672101256,0.44621117581662956
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.6095018290357832,0.45025535752449597
RAM2015_Log2 B,0.6114547359369776,0.4526554833557991
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.5949407258422904,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.6158068124830278,
WZ2023_Su_025_30min,0.6253778455130946,0.452533524695607
AH2018_LFQ_4_N,0.6127625993176931,
CR2017_Ratio Replicate 1.2,0.5767196141247837,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5886469183945164,
AH2018_SILAC_M_1_X,0.5901597743725359,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.566400958722167,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6001020416914272,0.4613991226658934
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.63133015976569,0.45038193647450925
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.6370814384972725,0.45212997556296514
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5910612102672468,0.4582954806803705
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,0.5759190116622107,
AH2018_LFQ_M_4_N,0.6171821969603608,0.44338988453197825
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.6107125637864579,
AH2018_LFQ_2_X,0.6129059133833726,0.4424447479150152
PG2020_Intensity 2h_B,0.6149940211688472,0.44424615704869186
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.6178170519384035,0.449151749372176
GF2025_P3_Sph,0.5872666308591205,0.45040341354436275
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5882961950230331,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4496922546717155
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6016201147250765,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.44230708055445866
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5743789691936029,
ZQ2022_N1,,
LY2019_P6-,0.5550627239676436,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5953315580411754,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.449117335616178
AH2018_LFQ_3_N,0.6135416464085145,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.6061139156355405,
UK2020_UA_1,0.5951736972048487,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.6064406730473931,0.4479997845561284
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.6136523473460207,
SR2019_BT549_Biol_repl_2,0.5737239278550811,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6251332465311368,0.4564266521230782
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5457838426234863,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5999012513028884,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.6061541486328876,0.4497672307057649
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.44951112347862127
PG2020_Intensity 10h_D,0.599097501772448,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.6075848235932323,0.44341371668666063
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.45219725374358494
AH2018_SILAC_MR_3_C,0.605718924416211,0.4525911303625679
AH2018_LFQ_M_4_C,0.6072429807989438,0.4465380583294064
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.4481288343727797
CK2022_6 40-1,0.6066778929757027,0.4484940506137406
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6067272084856662,
LY2019_P3-,0.5690509123338853,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.628415046411037,0.45507168953494165
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,0.4516564044821075
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.6171164952106901,
FS2019_Ctr3,0.6017004069414575,
WZ2023_Pu_025_20min,0.6251434778690638,0.45272033531195793
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5998987210394832,0.4504154186196683
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6368558586540758,0.4491129655214068
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.6349247557712859,0.4524638228247434
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5909091057690724,
LY2019_P8+,0.6021381586154047,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.559300539918944,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.45044129482131173
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6033281742546297,0.44388373419858307
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6097451401425457,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.6097186436147136,0.4507521760644443
LY2019_P2-,0.5625162084548483,
AH2018_LFQ_IT_1_X,0.589350571356184,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6288156832540065,0.45464705055458615
AST2020_Control.2,,0.45126530186555136
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6110552186156291,0.449966108631571
SR2019_MCF10A_Biol_repl_4,0.5615951786839903,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.6109766667365779,0.45097310955076575
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6064290795768507,
AH2018_TMTMS3_3_N,0.6357716002807835,0.4506244420736694
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6051251962478786,0.4417005284669383
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5886693654538145,0.4407921585539527
KBE2022_Log2_Ex_36_T,0.6058103158322968,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6267482913838227,0.45404970540212813
KS2014_Intensity C2,0.6463773609379545,0.45144706191103656
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.608010305228791,
CK2022_9 200-1,0.5953450743406359,0.45263902007902795
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5935038081843981,0.4521496343010991
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5911580925704921,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.576202516564668,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6488978436106961,0.45166571020148794
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6085748319606538,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5767057554391348,0.45382107085714485
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6268798523263172,0.45482201405612666
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6026078738093934,0.45858219687473306
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5805353433237566,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6085791900088198,0.4520188040663789
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.6124447453668013,0.448787440135555
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.606555062937287,0.45233888011816203
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.4530963063255743
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.611293750015374,0.442886914777194
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.5978372089837036,
AST2020_anti-CD3,,0.45069866501222156
SR2019_MDAMB231_Biol_repl_1,0.5900848938815251,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6273596038002072,0.4544862917785431
KBE2022_Log2_Ex_29_U,0.6090395644455971,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6177718660477594,0.4454448515990182
AH2018_LFQ_IT_4_N,0.6017618407733755,
CK2022_15 200-1,0.5999077594672247,0.45561312670395376
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5989484016988218,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5769726132617653,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6037214872821766,0.45488369446814625
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6244358064849258,0.4542031878132815
RN2012_H01,,0.45382070617611303
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.600220174880273,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6089357243423185,0.4449829371845021
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5999917309755164,
KBE2022_Log2_Ex_44_U,0.6031034616806629,
WZ2023_Pe_010_20min,0.6295267610933869,0.4535296886811471
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.632322662594513,0.441881720704738
FSO2013_Ratio H/M normalized Rep3___1,0.5852635160104193,
AH2018_SILAC_M_3_C,0.6027030587927796,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.6035285878269301,
AH2018_SILAC_M_2_X,0.600509492879774,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6063835135338594,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.626379492890225,0.45356987965028606
PG2020_Intensity 6h_C,0.6003995767425946,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.61803195991428,0.44645314727673463
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6347844343185443,0.44702854918725193
CK2022_15 16-1,0.600086660637455,0.4507343437097149
CK2022_3 16-1,0.6092180542291056,0.44981145621534746
LY2019_P4-,0.593341199274055,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5781645255388997,0.4527495238313969
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5874627824514558,0.4451486163386218
CK2022_10 16-1,0.5979914103124621,0.44527115268023726
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.453304319383468
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.5963843013725764,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5971337201239707,0.44150075052682924
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.6155632668915905,0.454186388323055
AR2021_L41 10 μM,0.5961641598071994,0.43849166892695585
CF2017_EOC 2,0.5976010344780389,0.4480173450118358
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5884665414247658,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.5953638752742799,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.6013644147943655,0.447660440204409
ZX2022_CB treated Replicate 1,0.6146083868866435,0.44860413466279947
BS2014_Log2(Ratio H/L normalized Rep_3),0.570877809166381,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6187040505223526,0.451676620958026
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6359868903896876,0.44673119457360627
AR2021_L41 1 μM,0.5968436934522964,0.45404390955175183
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6318244968722305,0.4456212557090776
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6193579189100034,0.44977708132309435
KS2014_Intensity C4,0.6322377676332648,0.45136379406630217
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6084939584585616,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.5722595968672667,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6186123230927898,0.4439228353689733
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5963700444799951,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5865066871234567,
WZ2023_Pu_025_10min,0.6264046486280385,0.45038256271839133
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5908131773988657,
SR2019_JIMT1_Biol_repl_4,0.5892578505648799,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.6047400031212193,0.4415818573391017
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6282532378944917,0.45252441470472476
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.6010159733678628,
KS2014_Intensity C6,0.6437104437295991,0.43639332602911224
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.6021450445075687,0.44764124138940353
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.6201468749390531,0.45110979917697497
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.6065708329621018,0.44998945774281957
AH2018_SILAC_IT_2_C,0.5875527423361204,
CK2022_5 40-1,0.606714294077879,0.44816800932741635
AH2018_LFQ_3_X,0.6123143973029801,
UK2020_UA_3,0.5960355757557166,
LY2019_P7-,0.6048376904732561,
GF2025_P5_Adh,0.595909037329747,0.44914596958088365
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5850201926161807,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5941377030259876,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6001741230293857,0.4463784650955395
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5919313134059617,
PG2020_Intensity CT_B,0.609701453438744,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6025042880988438,0.4524736775227699
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.6057844906239236,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6139600127121732,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6167941377498843,0.4451309165011935
YA2020_Reporter_intensity_Cancer_No.4,0.5974424790062978,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5837016672202202,0.44962769289904464
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5950418119231087,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.6013859351363255,0.45133470561165095
AST2020_anti-CD3+PDL2,,0.45169540758928683
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.6011451043796366,0.4431014541381552
AH2018_TMTMS2_1_X,0.6328441148880531,0.44778526612984604
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.5999091390776846,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.6144638951824757,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.6123794346344346,0.45233512334587395
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5893690566505292,
PG2020_Intensity 10h_B,0.5985304590141494,
AH2018_TMTMS3_1_X,0.6324405023599942,0.4521655524860949
CF2017_FTE 14,0.6109639046337325,0.4501246684759545
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5994184798771848,
SR2019_HCC1419_Biol_repl_3,0.5894249078516113,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5832565977354195,0.4688829044457624
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5957783243065056,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.6074094717562021,0.4391020079886879
AS2011_Ratio H/L Normalized RNAi_2_1,,
